David R. Powell
Lexicon Pharmaceuticals (United States)(US)Monash University(AU)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Growth Hormone and Insulin-like Growth Factors, Metabolism, Diabetes, and Cancer, Diabetes Management and Research
Most-Cited Works
- → Lrp5 functions in bone to regulate bone mass(2011)449 cited
- → Regulation and Function of Insulin-Like Growth Factor-Binding Protein-1(1993)390 cited
- → Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia(2013)296 cited
- → LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial(2012)237 cited
- → KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation(2013)197 cited
- → LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose(2013)181 cited